| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/28/2007 | DE102005054454A1 Verwendung von Choriongonadotropin als Immunsuppressivum Use of chorionic gonadotropin as an immunosuppressant |
| 06/28/2007 | CA2824075A1 Combination of r, r-glycopyrrolate, formoterol, and a glucocorticoid for the treatment of inflammatory diseases |
| 06/28/2007 | CA2816182A1 Pneumococcal polysaccharide conjugate vaccine |
| 06/28/2007 | CA2808919A1 Streptococcus pneumoniae capsular saccharide vaccine |
| 06/28/2007 | CA2634391A1 3- (4-{ ¬4-(4-{ ¬3-(3, 3-dimethyl-1-piperidinyl) propyl| 0xy} phenyl) -1-piperidinyl| carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 06/28/2007 | CA2634212A1 Mif inhibitors |
| 06/28/2007 | CA2634116A1 Anti-ilt7 antibody |
| 06/28/2007 | CA2634072A1 Markers for memory t cells and uses thereof |
| 06/28/2007 | CA2633776A1 Immuno-rna-constructs |
| 06/28/2007 | CA2633331A1 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | CA2633127A1 Method of producing rough strains of mycobacterium bacteria and uses thereof |
| 06/28/2007 | CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs |
| 06/28/2007 | CA2632780A1 Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases |
| 06/28/2007 | CA2632435A1 Soluble il-17rc variant and uses thereof |
| 06/28/2007 | CA2631653A1 Compounds having cytokine modulating properties |
| 06/28/2007 | CA2631069A1 Inhibitors of ccr9 activity |
| 06/28/2007 | CA2630889A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 06/28/2007 | CA2629088A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 06/27/2007 | EP1801216A2 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1801108A1 Morpholine compound |
| 06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 06/27/2007 | EP1800695A1 Immuno-RNA-constructs |
| 06/27/2007 | EP1800692A1 Novel adjuvant for subunit or component vaccines |
| 06/27/2007 | EP1800690A2 Use of fungal immunomodulatory protein |
| 06/27/2007 | EP1800673A2 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/27/2007 | EP1800670A1 Micellar drug delivery systems for hydrophobic drugs |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | EP1799267A2 Conjugates of hydroxyalkyl starch and a protein |
| 06/27/2007 | EP1799230A2 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 06/27/2007 | EP1799215A2 Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 06/27/2007 | EP1799053A2 Peptide mixture from peptides having a molecular weight of from 1000 to 5000 dalton |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1219630B1 Immunopotentiating compositions |
| 06/27/2007 | EP1212063B1 Topical azathioprine for the treatment of oral autoimmune diseases |
| 06/27/2007 | EP1140873B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/27/2007 | EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition |
| 06/27/2007 | CN1989245A Novel galectin 8 modification protein and use thereof |
| 06/27/2007 | CN1988901A Pharmaceutical products for treating neoplastic disease and inflammation |
| 06/27/2007 | CN1988899A The euphorbia lunulate bge extractant and production method and use thereof |
| 06/27/2007 | CN1985972A Method for preventing and treating diseases with serial lingzhigu coix seed granules |
| 06/27/2007 | CN1985943A Extraction process of aloe gel concentrate |
| 06/27/2007 | CN1985926A Compound kudzu vine root two purpose health beverage used as sauce and vinegar and medicine |
| 06/27/2007 | CN1985904A Chinese medicine composition with antioxidant and immunoregulating effects and its preparing method |
| 06/27/2007 | CN1985894A Chinese medicine for regulating body's immunity of tumor patient |
| 06/27/2007 | CN1985877A Astragalus extract and its medicine use |
| 06/27/2007 | CN1985875A Preparing process of Jade-screen total polyose |
| 06/27/2007 | CN1985874A Preparing method of Jade-screen micropill |
| 06/27/2007 | CN1985853A No-cell calmette-Guerin bacillus mucosa immune regulator and its application |
| 06/27/2007 | CN1985816A Oral disintegrated rupatadine tablet and its preparing method |
| 06/27/2007 | CN1985621A Bioactive peptide pre-mixing material and its use |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235555 Indolylmaleimide derivatives |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235541 Neurokinin antagonists for use as medicaments |
| 06/26/2007 | US7235528 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient |
| 06/26/2007 | US7235395 Lactic acid bacteria as agents for treating and preventing allergy |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/26/2007 | CA2154445C Lysosomal targeting of immunogens |
| 06/23/2007 | CA2571800A1 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/21/2007 | WO2007070514A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/21/2007 | WO2007069924A1 Deazapurine analogs of 4'-aza-l-nucleosides |
| 06/21/2007 | WO2007069923A1 Deazapurine analogs of 1'-aza-l-nucleosides |
| 06/21/2007 | WO2007069712A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069468A1 Cytokine secretion promoter |
| 06/21/2007 | WO2007069423A1 Diagnostic marker for allergy |
| 06/21/2007 | WO2007069378A1 Drug package |
| 06/21/2007 | WO2007068747A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 06/21/2007 | WO2007068047A1 Multimeric fc receptor polypeptides |
| 06/21/2007 | WO2007027714A3 Engineered anti-il-23 antibodies |
| 06/21/2007 | WO2006138429A3 Antibodies against hmgb1 and fragments thereof |
| 06/21/2007 | WO2006097530A3 Cat allergen fusion proteins and uses thereof |
| 06/21/2007 | WO2006078657A3 Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142465 Macrophage activation inhibitor |
| 06/21/2007 | US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 06/21/2007 | US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |